Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) Antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
ALOX5AP Antibody is a Goat Polyclonal antibody against ALOX5AP.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) |
| Host | Goat |
| Reactivity | Human |
| Recommended Dilution | P-ELISA: 1/128000. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Size 1 | 200 µl |
| Form | Liquid |
| Tested Applications | P-ELISA, WB, IHC |
| Buffer | Tris saline, pH 7.3, containing 0.02% sodium azide and 0.5% bovine serum albumin. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 241 |
| NCBI Accession | NP_001620.2, NP_001191335.1 |
| Alias | ALOX5AP,FLAP |
| Background | Antibody anti-ALOX5AP |
| Status | RUO |
| Note | Concentration: 0.5 mg/ml - |
Descripción
Arachidonate 5-Lipoxygenase Activating Protein (ALOX5AP) is a crucial regulatory protein that facilitates the activity of 5-lipoxygenase (5-LOX), an enzyme involved in the biosynthesis of leukotrienes. Leukotrienes are lipid mediators derived from arachidonic acid that play significant roles in inflammatory and allergic responses, including bronchoconstriction, vascular permeability, and recruitment of immune cells. ALOX5AP acts as an essential cofactor, enabling 5-LOX to translocate to the nuclear membrane and interact with its substrate, leading to the production of leukotrienes. Dysregulation of ALOX5AP has been implicated in various inflammatory diseases, including asthma, atherosclerosis, and rheumatoid arthritis. Genetic variants in the ALOX5AP gene are associated with an increased risk of cardiovascular disease and stroke, making it a potential biomarker and therapeutic target. Inhibitors targeting ALOX5AP or its interaction with 5-LOX are being explored as treatments to mitigate leukotriene-mediated inflammatory conditions.
Related Products
Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) Antibody
ALOX5AP is a protein which, with 5-lipoxygenase, is required for leukotriene synthesis. Leukotrienes are arachidonic acid metabolites which have been implicated in various types of inflammatory responses, including asthma, arthritis and psoriasis. This protein localizes to the plasma membrane. Inhibitors of its function impede translocation of 5-lipoxygenase from the cytoplasm to the cell membrane and inhibit 5-lipoxygenase activation.
Ver Producto
Rat Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) ELISA Kit
Rat Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Rat Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) concentrations in tissue homogenates, cell lysates and other biological fluids.
Ver Producto
Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) Peptide
Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) Peptide is a synthetic peptide.
Ver Producto